- Home
- ESPR vs RLGT Comparison
ESPR vs RLGT Comparison
Compare ESPR & RLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- RLGT
- Stock Information
- Founded
- ESPR 2008
- RLGT 2001
- Country
- ESPR United States
- RLGT United States
- Employees
- ESPR N/A
- RLGT N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- RLGT Oil Refining/Marketing
- Sector
- ESPR Health Care
- RLGT Consumer Discretionary
- Exchange
- ESPR Nasdaq
- RLGT Nasdaq
- Market Cap
- ESPR 305.0M
- RLGT 317.8M
- IPO Year
- ESPR 2013
- RLGT N/A
- Fundamental
- Price
- ESPR $1.49
- RLGT $6.41
- Analyst Decision
- ESPR Buy
- RLGT
- Analyst Count
- ESPR 7
- RLGT 0
- Target Price
- ESPR $6.36
- RLGT N/A
- AVG Volume (30 Days)
- ESPR 4.0M
- RLGT 161.1K
- Earning Date
- ESPR 03-04-2025
- RLGT 05-08-2025
- Dividend Yield
- ESPR N/A
- RLGT N/A
- EPS Growth
- ESPR N/A
- RLGT 32.26
- EPS
- ESPR N/A
- RLGT 0.29
- Revenue
- ESPR $332,314,000.00
- RLGT $858,699,000.00
- Revenue This Year
- ESPR $5.51
- RLGT $12.86
- Revenue Next Year
- ESPR $1.42
- RLGT $5.75
- P/E Ratio
- ESPR N/A
- RLGT $21.95
- Revenue Growth
- ESPR 185.66
- RLGT N/A
- 52 Week Low
- ESPR $1.47
- RLGT $4.83
- 52 Week High
- ESPR $3.94
- RLGT $7.94
- Technical
- Relative Strength Index (RSI)
- ESPR 34.95
- RLGT 40.42
- Support Level
- ESPR $1.47
- RLGT $6.19
- Resistance Level
- ESPR $1.61
- RLGT $6.52
- Average True Range (ATR)
- ESPR 0.13
- RLGT 0.22
- MACD
- ESPR -0.01
- RLGT -0.04
- Stochastic Oscillator
- ESPR 7.69
- RLGT 23.12
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.